CPRX
WatchlistCatalyst Pharmaceuticals, Inc.
Healthcare · NASDAQ
$3.9B mkt cap
Brief updated Today
Catalyst Pharmaceuticals, Inc., founded in 2002 and based in Coral Gables, Florida, operates as a commercial-stage biopharmaceutical enterprise. This company is dedicated to discovering, developing, and marketing therapeutic solutions for individuals in the United States who are afflicted with uncom
CPRX driven by biotech growth
Catalyst Pharmaceuticals operates in the biotechnology sector with a high gross margin of 8232.0%. The company's revenue growth of 5.6% year-over-year and net margin of 3708.0% are notable. The conviction score of 27/100 indicates a cautious outlook, despite an analyst consensus rating of BUY. This contrast makes the setup interesting, with a DCF intrinsic value of $137,
Why now
The current macro context, with a focus on healthcare and biotech, makes this a crucial moment to assess CPRX's prospects. The company's unique financial profile, with exceptionally high margins, warrants attention amidst the broader market dynamics,
Key risks
Valuation risk is a concern, given the high P/E ratio of 17.4x. Execution risk also exists, as the company's ability to maintain its high margins and revenue growth is uncertain. Additionally, competitive risk in the biotechnology sector poses a threat to CPRX's market position,
What to watch
The company's future revenue growth and margin maintenance will be key indicators to confirm or deny the thesis. Investors should monitor CPRX's performance over the next few quarters, particularly its ability to sustain a high net margin and deliver on its growth prospects,
Catalyst Pharmaceuticals, Inc. operates in biotechnology. That places it inside the Healthcare, Biotech & Devices story.
Trump Criticized Biden for Draining America’s Oil Reserves. They’re Now at a 43-Year Low Amidst a Middle East War.
US Strategic Petroleum Reserve levels have fallen to a 43-year low, reducing the government's capacity to buffer oil price shocks at a time of active Middle East conflict. This structural vulnerability in US energy policy raises concerns about energy security and the ability to respond to supply disruptions.
6d ago
Trump Criticized Biden for Draining America’s Oil Reserves. They’re Now at a 43-Year Low Amidst a Middle East War.
US Strategic Petroleum Reserve levels have fallen to a 43-year low amid an active Middle East conflict, reducing America's buffer capacity against oil supply disruptions. This constrains the US government's ability to intervene in energy markets during a period of elevated geopolitical risk.
6d ago
U.S. Central Command Posts On X "At 5:45 p.m. ET today, Islamic Revolutionary Guard Corps forces launched multiple ballistic missiles from Iran in an attempted surprise attack on U.S. forces based in the Middle East. All Iranian missiles were successfully intercepted. U.S. forces remain vigilant and at a high state of readiness."
Iranian IRGC forces launched a ballistic missile attack on U.S. military positions in the Middle East, which was fully intercepted according to U.S. Central Command. This represents a direct state-on-state military strike against U.S. forces, dramatically escalating regional tensions and raising the risk of broader conflict.
6d ago
Equities Lower Intraday Ahead of Fed Decision, Major Tech Earnings
The equities market is experiencing intraday losses ahead of the highly anticipated Federal Reserve decision, which could significantly impact market direction and investor sentiment. The decision, coupled with major tech earnings reports, is poised to influence the overall economic outlook.
5d ago
Earnings surprises
-18.8%
2026-05
+61.9%
2026-02
+33.3%
2025-11
+17.2%
2025-08
+28.3%
2025-05
Generated Tue, 04 Aug 2026 06:47:59 GMT by Decifer intelligence engine. For informational purposes only — not investment advice. Decifer Intelligence Hub.